SBIR-STTR Award

Antibacterial nanoparticles as insecticide synergists and insect growth regulators for improved control of cockroach infestations
Award last edited on: 3/1/2022

Sponsored Program
STTR
Awarding Agency
NIH : NIAID
Total Award Amount
$257,554
Award Phase
1
Solicitation Topic Code
855
Principal Investigator
Jose Enrique Pietri

Company Information

Apex Bait Technologies Inc

309 Laurelwood Road Unit 18-2
Santa Clara, CA 95054
   (408) 969-0088
   N/A
   www.apexbait.com

Research Institution

----------

Phase I

Contract Number: 1R41AI162017-01
Start Date: 4/9/2021    Completed: 3/31/2023
Phase I year
2021
Phase I Amount
$257,554
The prevalence of asthma in the United States is approximately 8% (>25 million people). In African Americans, the prevalence is >11%. A majority of asthma sufferers are sensitized to allergens, including those shed in the feces, saliva, and exuviae of cockroaches. Thus, exposure to cockroach infestation is recognized as both a significant risk factor for the development of allergic asthma and a potent trigger of asthma attacks. The asthma risk from cockroach exposure is particularly high in inner-city residences where elevated levels of cockroach allergens are common. For example, some studies have shown that cockroach allergens are found at high concentrations associated with asthma in >45% of high-rise apartments in the U.S., and >60% of asthmatic children in U.S. inner cities are sensitized to cockroach allergens. Treating active cockroach infestations can significantly reduce allergen levels within structures and is one strategy to improve asthma symptoms that is recommended by the National Asthma Education and Prevention Board. The German cockroach, Blatella germanica, is the most widespread and problematic cockroach pest in urban environments. The use of insecticidal baits has traditionally been the most effective method for control of this species. However, the spread of insecticide resistance across populations of B. germanica can reduce the efficacy of insecticidal interventions, creating a need for improved tools. Our research team recently reported that the gut microbiota contributes to insecticide resistance in B. germanica. We also found that disrupting the gut microbiota decreases reproductive fitness. Accordingly, we predict that targeting the microbiota of German cockroaches by incorporating antibacterial metal oxide nanoparticles into insecticidal bait formulations could be an effective strategy to improve control of insecticide-resistant infestations in the field. We propose three specific aims to test the viability of this approach against cockroaches resistant to diverse insecticides using two types of metal oxide nanoparticles with known antibacterial properties (ZnO and CuO). In aim 1, we will determine if antibacterial nanoparticles can increase the efficacy of several commonly used bait insecticides against resistant cockroach strains. In aim 2, we will determine if antibacterial nanoparticles in bait can adversely affect cockroach life history. In aim 3, we will determine if nanoparticle-insecticide combination baits can eliminate resistant cockroach populations under semi-field conditions. It is expected that the results of our work will inform the development of novel insecticidal bait formulations to mitigate insecticide resistance and improve cockroach control, which has been demonstrated to reduce asthma morbidity and improve outcomes in human populations. Public Health Relevance Statement STATEMENT OF PUBLIC HEALTH RELEVANCE There is a clear relationship between exposure to cockroach allergens and allergic asthma morbidity in both children and adults. Prior studies have established that interventions to reduce cockroach allergen levels, particularly insecticidal treatments that decrease cockroach populations, can significantly reduce morbidity and improve outcomes in asthma sufferers. Results from our work will enhance the efficacy of insecticidal formulations for more efficient control of cockroach infestations, thereby directly reducing cockroach- associated health risks and improving environmental hygiene in human homes.

Project Terms:
Adult ; 21+ years old ; Adult Human ; adulthood ; Affect ; Age ; ages ; Agriculture ; agricultural ; Allergens ; Animal Diseases ; Antibiotics ; Antibiotic Agents ; Antibiotic Drugs ; Miscellaneous Antibiotic ; Asthma ; Bronchial Asthma ; Chemistry ; Child ; 0-11 years old ; Child Youth ; Children (0-21) ; youngster ; Dictyoptera ; Cockroaches ; Copper ; Cu element ; Doxycycline ; Vibramycin ; alpha-6-Deoxyoxytetracycline ; Education ; Educational aspects ; Feces ; stool ; Gel ; Goals ; Growth ; Generalized Growth ; Tissue Growth ; ontogeny ; Health ; Household ; Human ; Modern Man ; Hygiene ; Insecticide Resistance ; insecticide resistant ; Insecticides ; Insecta ; Insects ; Insects Invertebrates ; Juvenile Hormones ; Insect Growth Regulators ; Kinetics ; Lead ; Pb element ; heavy metal Pb ; heavy metal lead ; Longevity ; Length of Life ; life span ; lifespan ; Methods ; Morbidity - disease rate ; Morbidity ; mortality ; Oxides ; Physiology ; Research ; Risk ; Risk Factors ; Saliva ; South Dakota ; Technology ; Testing ; Time ; United States ; Universities ; Work ; Zinc Oxide ; Lassar's Paste ; Measures ; African American ; Afro American ; Afroamerican ; Black Populations ; black American ; Antibiotic Resistance ; Resistance to antibiotics ; Resistant to antibiotics ; antibiotic drug resistance ; antibiotic resistant ; Extrinsic asthma ; Allergic asthma ; atopic asthma ; extrinsic allergic asthma ; improved ; fipronil ; residence ; residential building ; residential site ; Individual ; Anti-Bacterial Agents ; Antibacterial Agents ; anti-bacterial ; antibacterial ; Exposure to ; tool ; German ; German population ; interest ; inner city ; metal oxide ; Performance ; life history ; trait ; Structure ; novel ; offspring ; Prevention ; Reporting ; reproductive ; Property ; Intervention Strategies ; interventional strategy ; Intervention ; indoxacarb ; Effectiveness ; small molecule ; cockroach allergen ; Low income ; Symptoms ; Development ; developmental ; feeding ; nanoparticle ; nano particle ; nano-sized particle ; nanosized particle ; Resistance development ; Resistant development ; developing resistance ; Population ; Prevalence ; Resistance ; resistant ; public health relevance ; resistant strain ; resistance strain ; gut microbiota ; GI microbiota ; Gastrointestinal microbiota ; enteric microbial community ; enteric microbiota ; gastrointestinal microbial flora ; gut commensal ; gut community ; gut flora ; gut microbe community ; gut microbial community ; gut microbial composition ; gut microbial consortia ; gut microbiotic ; gut microflora ; intestinal flora ; intestinal microbes ; intestinal microbiota ; intestinal microflora ; intestinal tract microflora ; asthmatic ; Formulation ; improved outcome ; reproductive fitness ; microbiota ; microbial consortia ; microbial flora ; microflora ; multispecies consortia ; negative affect ; negative affectivity ; experimental study ; experiment ; experimental research ; urban setting ; urban environment ; asthma exacerbation ; asthma attack ; exacerbation in asthma ; exacerbation prone asthma ; exacerbation prone asthmatic ; Home ;

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----